Influence of cytomegalovirus disease in outcome of solid organ transplant patients

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2145-2148

  Linares, L ^a   Sanclemente, G ^a   Cervera, C ^a   Hoyo, I ^a   Cofan F ^a   Ricart, M J ^a   Perez Villa F ^a   Navasa, M ^a   Marcos, M A ^a   Anton A ^a   Pumarola, T ^a   Moreno, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; GANCICLOVIR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; COLITIS; CYTOMEGALOVIRUS INFECTION; DIALYSIS; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTRITIS; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; REOPERATION; SEROLOGY;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051683456     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.007     Document Type: Article

References (15)

1. A.P. Limaye, R. Bakthavatsalam, and H.W. Kim Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis Transplantation 81 2006 1645
2. S.K. Arthurs, A.J. Eid, and R.A. Pedersen Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation Clin Infect Dis 46 2008 840
3. C. Cervera, M. Pineda, and L. Linares Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients Transplant Proc 39 2007 2228
4. C. Cervera, F. Lozano, and L. Linares Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation Transplant Proc 41 2009 2259
5. C. Cervera, F. Lozano, and N. Saval The influence of innate immunity gene receptors polymorphisms in renal transplant infections Transplantation 83 2007 1493
6. A. Fica, C. Cervera, and N. Perez Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests Transpl Infect Dis 9 2007 203
7. R.H. Rubin The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the "silo hypothesis." Curr Opin Infect Dis 20 2007 399
8. A. Humar, and M. Michaels American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Am J Transplant 6 2006 262
9. J. Torre-Cisneros, A. Doblas, and J.M. Aguado Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort Clin Infect Dis 48 2009 1657
10. P. Ljungman, P. Griffiths, and C. Paya Definitions of cytomegalovirus infection and disease in transplant recipients Clin Infect Dis 34 2002 1094
11. R. San Juan, J.M. Aguado, and C. Lumbreras Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group Am J Transplant 7 2007 964
12. B. Kranz, U. Vester, and A.M. Wingen Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection Pediatr Transplant 12 2008 474
13. R.R. Razonable, A. Rivero, and R.A. Brown Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection Clin Transplant 17 2003 114
14. R. San Juan, J.M. Aguado, and C. Lumbreras Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation Clin Infect Dis 47 2008 875
15. C. Paya, A. Humar, and E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611